HCA Healthcare names Michael Schlosser chief clinical officer effective Sept. 1
Reuters2026/08/06 12:34- HCA Healthcare named Michael Schlosser executive vice president, chief clinical officer, effective Sept. 1, 2026.
- Schlosser is senior vice president, chief transformation officer; previously group chief medical officer for the National Group.
- He will succeed Michael Cuffe, who will step down Aug. 31; Cuffe will serve as executive consultant through February 2027.
- Charles Gressle will become president of the new Ambulatory Operations Group on Sept. 1; he currently leads the East Florida Division.
- Gressle will oversee physician services, urgent care, physician practice operations, surgery ventures within a network of more than 2,700 facilities.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Citadel Securities sounds the alarm: September “curse” combined with cheap options, short-term risk-reward in US stocks deteriorates sharply
September is typically the worst-performing month for U.S. stocks, with the S&P 500's average monthly return at its lowest point of the year. Currently, option prices are also at their cheapest level of the year—combining these two factors makes the risk-reward ratio of buying downside protection particularly attractive.

Arista Networks 10% owner Andreas Bechtolsheim sells USD 60.02 million in common shares
Zyus Life Sciences completes CAD 1.95 million secured loan financing at 12% interest